Hyperthermia is an additional option in the treatment of squamous cell cancer of the anal canal


如何引用文章

全文:

详细

Purpose: to estimate the rate of locoregional recurrence and distant metastases, and the grade of chemoradiotherapy toxicity when in combination with local hyperthermia for treating squamous cell anal canal cancer T1-4N0,1-3M0-1. Materials and methods. 112 patients with squamous cell anal canal cancer were treated between 2011 and 2015 with chemotherapy, radiation therapy based on 3D CRT, intensity-modulated radiation therapy (IMRT) and volumetric intensity modulated arc therapy (VMAT), and local hypothermia. Staging was based on TNM (7th edition): I - 4 (3.6%) patients, II - 39 (34.8%) patients; IIIA - 33 (29.5%) patients, IIIB - 34 (30.3%) patients and IV - 2 (1.8%) patients. The median of mean follow-up was 32 months (range, 3-63 months). Local hyperthermia was performed in 81 (72.3%) patients. Results. 2-year local control was 73.2%. All recurrences, no matter which chemotherapy was performed, were in patients with advanced disease (IIIA/IIIB stages), from which 22.2% relapses were in group without local hyperthermia vs. 4.7% in group with radiomodification, p=0.038. Distant metastases were found in 9.4% patients with hyperthermia and in 11.1% patients without radiomodification, p=1. Usage of local hyperthermia is associated with increase II grade of dermatological toxicity (p=0.056). Conclusion. The combination of local hyperthermia and modern technologies of conformal radiation therapy has influenced the decrease of locoregional recurrences, but it is associated with lack of influence on distant metastases appearance regardless on chemotherapy regimen.

作者简介

V Glebovskaya

N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation

Email: oncovalery@mail.ru
канд. мед. наук, ст. науч. сотр. отд-ния радиологического НИИ КиЭР ФГБНУ «РОНЦ им. Н.Н.Блохина» 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23

S Tkachev

N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation

д-р мед. наук, проф., вед. науч. сотр. отд-ния радиологического НИИ КиЭР ФГБНУ «РОНЦ им. Н.Н.Блохина» 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23

S Ivanov

N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation

канд. мед. наук, ст. науч. сотр. отд-ния радиологического НИИ КиЭР ФГБНУ «РОНЦ им. Н.Н.Блохина» 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23

A Nazarenko

N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation

канд. мед. наук, зав. отд-нием радиологического НИИ КиЭР ФГБНУ «РОНЦ им. Н.Н.Блохина» 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23

A Rasulov

N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation

д-р мед. наук, зав. отд-нием хирургическим №3 проктологическим НИИ клинической онкологии ФГБУ «РОНЦ им. Н.Н.Блохина» 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23

S Gordeev

N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation

канд. мед. наук, врач отд-ния хирургического №3 проктологического НИИ клинической онкологии ФГБУ «РОНЦ им. Н.Н.Блохина» 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23

P Bulychkin

N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation

врач отд-ния радиологического НИИ КиЭР ФГБНУ «РОНЦ им. Н.Н.Блохина» 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23

N Besova

N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation

канд. мед. наук, ст. науч. сотр. отд-ния химиотерапии НИИ клинической онкологии ФГБУ «РОНЦ им. Н.Н.Блохина» 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23

U Barsukov

N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation

д-р мед. наук, вед. науч. сотр. отд-ния хирургического №3 проктологического НИИ клинической онкологии ФГБУ «РОНЦ им. Н.Н.Блохина» 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23

O Trofimova

N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation

д-р мед. наук, вед. науч. сотр. отд-ния радиологического НИИ КиЭР ФГБНУ «РОНЦ им. Н.Н.Блохина» 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23

T Borisova

N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation

канд. мед. наук, ст. науч. сотр. отд-ния радиологического НИИ КиЭР ФГБНУ «РОНЦ им. Н.Н.Блохина» 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23

E Timoshkina

N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation

врач отд-ния радиологического НИИ КиЭР ФГБНУ «РОНЦ им. Н.Н.Блохина» 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23

参考

  1. Van der Zee J, González González D, van Rhoon G.C et al. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000; 355: 1119-25.
  2. Hurwitz M, Stauffer P. Hyperthermia, radiation and chemotherapy: the role of heat in multidisciplinary cancer care. Semin Oncol 2014; 41: 714-29.
  3. Horsman M.R, Overgaard J. Hyperthermia: a potent enhancer of radiotherapy. Clin Oncol (R Coll Radiol) 2007; 19: 418-26.
  4. Dewey W.C. Arrhenius relationships from the molecule and cell to the clinic. Int J Hyperthermia 1994; 10: 457-83.
  5. Ткачев С.И. Сочетанное применение лучевой терапии и локальной гипертермии в лечении местнораспространенных новообразований. Дис. … д - ра мед. наук, 1994.
  6. Кныш В.И., Тимофеев Ю.М. Злокачественные опухоли анального канала. М., 1997.
  7. Малихов А.Г. Комбинированное и комплексное лечение больных плоскоклеточным раком анального канала. Дис. … канд. мед. наук. М., 2003.
  8. Skitzki J.J, Repasky E.A, Evans S.S. Hyperthermia as an immunotherapy strategy for cancer. Curr Opin Investig Drugs 2009; 10 (6): 550-8.
  9. Bull J.M.C, Strebel F.R, Jenkins G.N et al. The importance of schedule in whole body thermochemotherapy. Int J Hyperthermia 2008; 24 (2): 171-81.
  10. Liang X.H, He Y.W, Tang Y.L et al. Thermochemotherapy of lower lip squamous cell carcinoma without metastases: an experience of 31 cases. J Craniomaxillofac Surg 2009.
  11. Atmaca A, Al-Batran S.E, Neumann A et al. Whole - body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer: a phase II study. Gynecol Oncol 2009; 112 (2): 384-8.
  12. Thrall D.E, La Rue S.M, Yu D et al. Thermal dose is related to duration of local control in canine sarcomas treated with thermoradiotherapy. Clin Cancer Res 2005; 11 (14): 5206-14.
  13. Arora D, Skliar M, Roemer R.B. Minimum - time thermal dose control of thermal therapies. IEEE Trans Biomed Eng 2005; 52 (2): 191-200.
  14. Jones E.L, Pronisnitz L.R, Dewhirst M.W et al. In regard to Vasanathan et al. Int J Radiat Oncol Biol Phys 2005; 63: 644.
  15. Vernon C.C, Hand J.W, Field S.B et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International collaborative hyperthermia group. Int J Radiat Oncol Biol Phys 1996; 35: 731-44.
  16. Franckena M, Canters R, Termorshuizen F et al. Clinical implementation of hyperthermia treatment planning guided steering: a cross over trial to assess its current contribution to treatment quality. Int J Hyperthermia 2010; 26: 145-57.
  17. Franckena M, Stalpers L.J, Koper P.C et al. Long - term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch deep hyperthermia trial. Int J Radiat Oncol Biol Phys 2008; 70: 1176-82.
  18. Berdov B.A, Menteshashvili G.Z. Thermoradiotherapy of patients with locally advanced carcinoma of the rectum. Int J Hyperthermia 1990; 6: 881-90.
  19. De Haas-Kock D.F, Buijsen J, Pijls-Johannesma M et al. Concomitant hyperthermia and radiation therapy for treating locally advanced rectal cancer. Cochrane Database Syst Rev 2009; CD006269.
  20. Rau B, Benhidjeb T, Wust P, Schlag P.M. Stellenwert der Hyperthermie fur die chirurgische Onkologie. German Viszeralchirurgie 2002; 37: 379-84.
  21. Issels R.D, Lindner L.H, Verweij J et al. Neoadjuvant chemotherapy alone or with regional hyperthermia for localized high - risk soft - tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol 2010; 11: 561-70.
  22. Overgaard J, Gonzalez Gonzalez D, Hulshof M.C et al. Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. Int J Hyperthermia 1996; 12: 3-20.
  23. Kouloulias V, Plataniotis G, Kouvaris J et al. Chemoradiotherapy combined with intracavitary hyperthermia for anal cancer: feasibility and long - term results from a phase II randomized trial. Am J Clin Oncol 2005; 28: 91-9.
  24. Colombo R, Salonia A, Leib Z et al. Long - term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin - c alone as adjuvant treatment for non - muscle - invasive bladder cancer (nmibc). BJU Int 2011; 107: 912-8.
  25. Ott O.J, Rodel C, Weiss C et al. Radiochemotherapy for Bladder Cancer. Clin Oncol (R Coll Radiol) 2009; 21: 557-65.
  26. Wittlinger M, Rodel C.M, Weiss C et al. Quadrimodal treatment of high - risk T1 and T2 bladder cancer: transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia. Radiother Oncol 2009; 93: 358-63.
  27. Gellermann J, Wlodarczyk W, Hildebrandt B et al. Noninvasive magnetic resonance thermography of recurrent rectal caecinoma in a 1.5 Tesla hybrid system. Cancer Res 2005; 65: 5872-80.
  28. Gellermann J, Hildebrandt B, Issels R et al. Noninvasive magnetic resonance thermography of soft tissue sarcomas during regional hyperthermia: correlation with response and direct thermometry. Cancer 2006; 107: 1373-82.
  29. Datta N.R, Puric E, Schneider R et al. Could hyperthermia with proton therapy mimic carbon ion therapy? Exploring a thermo - radiobiological rationale. Int J Hyperthermia 2014; 30: 524-30.
  30. Issels R. Hyperthermia combined with chemotherapy - biological rationale, clinical application, and treatment results. Onkologie 1999; 22: 374-81.
  31. Dewhirst M.W, Vujaskovic Z, Jones E, Thrall D. Re - setting the biologic rationale for thermal therapy. Int J Hyperthermia 2005; 21: 779-90.
  32. Sneed P.K, Stauffer P.R, Mc Dermott M.W et al. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1998; 40: 287-95.
  33. Zhao C, Chen J, Yu B, Chen X. Improvement in quality of life in patients with nasopharyngeal carcinoma treated with non - invasive extracorporeal radiofrequency in combination with chemoradiotherapy. Int J Radiat Biol 2014; 90: 853-8.
  34. Cox J.D et al. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31 (5): 1341-6.
  35. Sugimachi K, Kuwano H, Ide H et al. Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma: a prospective randomized trial. Int J Hyperthermia 1994; 10: 485-93.
  36. Schaffer M, Krych M, Pachmann S et al. Feasibility and morbidity of combined hyperthermia and radiochemotherapy in recurrent rectal cancer - preliminary results. Onkologie 2003; 26: 120-4.
  37. Голдобенко Г.В., Дурнов Л.А., Кныш В.И. и др. Опыт терморадиотерапии злокачественных опухолей. Мед. радиология. 1987; 1: 36-8.

版权所有 © Consilium Medicum, 2017

Creative Commons License
此作品已接受知识共享署名-非商业性使用 4.0国际许可协议的许可。
 


##common.cookie##